Epcoritamab has been added to the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for B-cell Lymphomas in the third- or later-line setting for the treatment of patients with diffuse large B-cell lymphoma.
Guidelines | Diffuse Large B-Cell Lymphoma Guideline Updates 2023
Diffuse Large B-Cell Lymphoma Guideline Updates 2023
Articles
Videos
In his closing thoughts, Dr Gordon discusses navigation of treatment resistance in DLBCL management.
The impact of collaborative care in DLBCL treatment is explored by a medical expert.
Advertisement
Advertisement
Trending on AJMC
1
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
2
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
3
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD
4
GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms
5
